Literature DB >> 8066571

Bordetella bronchiseptica pneumonia in a patient with AIDS.

J de la Fuente1, C Albo, A Rodríguez, B Sopeña, C Martínez.   

Abstract

Bordetella bronchiseptica is recognised as a respiratory tract pathogen in many mammalian species, but has rarely been implicated in human infection. A case is reported of pneumonia caused by B bronchiseptica in a patient suffering from acquired immunodeficiency syndrome (AIDS).

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8066571      PMCID： PMC475067          DOI： 10.1136/thx.49.7.719

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  8 in total

1.  Recovery of Bordetella bronchiseptica from patients with AIDS.

Authors:  V L Ng; J M Boggs; M K York; J A Golden; H Hollander; W K Hadley
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

2.  [Pneumonia caused by Bordetella bronchiseptica in a patient with Crohn's disease].

Authors:  J Cuesta; T Hermosilla; B Gros; S Zabala; M C García
Journal:  An Med Interna       Date:  1991-10

3.  Pneumonia due to Bordetella bronchiseptica in a patient with AIDS.

Authors:  C Amador; E Chiner; J L Calpe; V Ortiz de la Table; C Martinez; F Pasquau
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

4.  Pneumonia due to Bordetella bronchiseptica in a patient with AIDS.

Authors:  G R Decker; J P Lavelle; P N Kumar; P F Pierce
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

5.  Nonfermentative gram-negative bacilli of nosocomial interest.

Authors:  P Gardner; W B Griffin; M N Swartz; L J Kunz
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

Review 6.  Biology of Bordetella bronchiseptica.

Authors:  R A Goodnow
Journal:  Microbiol Rev       Date:  1980-12

Review 7.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Uptake of ciprofloxacin by macrophages.

Authors:  C S Easmon; J P Crane
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411
  8 in total
  9 in total

1.  Bordetella bronchiseptica cavitary pneumonia in a patient with AIDS.

Authors:  L García San Miguel; C Quereda; M Martínez; P Martín-Dávila; J Cobo; A Guerrero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

Review 2.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Bordetella bronchiseptica pneumonia.

Authors:  R A Lawson
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

4.  Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs.

Authors:  P Stefanelli; P Mastrantonio; S Z Hausman; M Giuliano; D L Burns
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  bvg Repression of alcaligin synthesis in Bordetella bronchiseptica is associated with phylogenetic lineage.

Authors:  P C Giardina; L A Foster; J M Musser; B J Akerley; J F Miller; D W Dyer
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

6.  Cavitary pneumonia in an AIDS patient caused by an unusual Bordetella bronchiseptica variant producing reduced amounts of pertactin and other major antigens.

Authors:  Benito Lorenzo-Pajuelo; José Luis Villanueva; Juan Rodríguez-Cuesta; Nuria Vergara-Irigaray; Máximo Bernabeu-Wittel; Andrés Garcia-Curiel; Guillermo Martínez de Tejada
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host.

Authors:  P Gueirard; C Weber; A Le Coustumier; N Guiso
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

8.  Kitten-transmitted Bordetella bronchiseptica infection in a patient receiving temozolomide for glioblastoma.

Authors:  Gil Redelman-Sidi; Christian Grommes; Genovefa Papanicolaou
Journal:  J Neurooncol       Date:  2010-07-30       Impact factor: 4.506

9.  Type Six Secretion System of Bordetella bronchiseptica and Adaptive Immune Components Limit Intracellular Survival During Infection.

Authors:  Liron Bendor; Laura S Weyrich; Bodo Linz; Olivier Y Rolin; Dawn L Taylor; Laura L Goodfield; William E Smallridge; Mary J Kennett; Eric T Harvill
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.